United States
Premiumsupplier
Ladiratuzumab vedotin CAS NO.1629760-29-7
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- SGN-LIV1A
- Anti-LIV-1 ADC
Quick Details
- ProName: Ladiratuzumab vedotin
- CasNo: 1629760-29-7
- Application: For research use only.
- Purity: 95%
- LimitNum: 0
Superiority
We provide customized and high-quality Ladiratuzumab vedotin product for your project.
Details
Ladiratuzumab vedotin is an antibody-drug conjugate consisting of a humanized anti-LIV-1 IgG1 conjugated with monomethyl auristatin E (MMAE). Ladiratuzumab vedotin has the potential for the treatment of metastatic triple-negative breast cancer.
